Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NS6Z
|
|||
| Drug Name |
COH29
|
|||
| Synonyms |
Coh-29; COH-29; UNII-07802BU06S; 07802BU06S; 1190932-38-7; Rnr inhibitor COH29; SCHEMBL10036527; MolPort-044-567-552; AKOS032944935; CS-6153; HY-19931; N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide; Benzamide, N-(4-(3,4-dihydroxyphenyl)-5-phenyl-2-thiazolyl)-3,4-dihydroxy-
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Novonco Therapeutics Los Angeles, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H16N2O5S
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=C(N=C(S2)NC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O
|
|||
| InChI |
1S/C22H16N2O5S/c25-15-8-6-13(10-17(15)27)19-20(12-4-2-1-3-5-12)30-22(23-19)24-21(29)14-7-9-16(26)18(28)11-14/h1-11,25-28H,(H,23,24,29)
|
|||
| InChIKey |
LGGDLPSXAGQFSG-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1190932-38-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ribonucleotide reductase (RIR) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.